More stories

  • in

    Cognitive difficulties tied to lower return to work after breast cancer

    Return to work two years after a breast most cancers analysis is related to larger cognitive pace efficiency earlier than and after therapy, in accordance with a examine revealed on-line Aug. 19 in JAMA Network Open. Marie Lange, Ph.D., from Normandie Université UNICAEN in Caen, France, and colleagues examined whether or not cognition, assessed utilizing […] More

  • in

    Dialyl-sulfide and trans-chalcone prevent breast cancer by targeting SULT1E1 and HIF1a-MMPs

    Schematic illustration of breast most cancers affiliation with redox-regulated SULT1E1 dysfunction and HIF1a/MMPs up-regulations. The outstanding therapeutic function of Dialyl-sulfide (DAS) and chalcone by way of reversal of those protein dysfunctions has been summarized. Credit: Nazmeen et al. A brand new analysis paper was revealed inGenes & Cancer on August 9, 2024, titled “Dialyl-sulfide with […] More

  • in

    Breast cancer survival improved in Gaza between 2017–2020, finds study

    Credit: Pixabay/CC0 Public Domain A latest research shines mild on the remedy and survival outcomes for ladies with breast most cancers in Gaza earlier than the present battle. While over half of reported diagnoses have been made at superior phases, a excessive short-term survival charge was found, highlighting the optimistic influence of worldwide funding and […] More

  • in

    Improved survival found for breast cancer patients with dose-dense chemotherapy

    Cumulative incidence curves of efficacy finish factors within the intention-to-treat inhabitants. Credit: Journal of Clinical Oncology. DOI: 10.1200/JCO.24.00178 Dose-dense adjuvant chemotherapy can enhance survival for sufferers with high-risk breast most cancers, in response to a workforce of researchers that features the Karolinska Institutet. The worldwide PANTHER trial, which studied greater than 2,000 sufferers the place […] More